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Importance 
Glanders is a serious zoonotic bacterial disease that primarily affects horses, mules 
and donkeys. Some animals die acutely within a few weeks. Others become chronically 
infected, and can spread the disease for years before succumbing. Glanders also occurs 
occasionally in other mammals, including carnivores that eat meat from infected 
animals. Although cases in humans are uncommon, they can be life threatening and 
painful. Without antibiotic treatment, the case fatality rate may be as high as 95%.  
Glanders was a worldwide problem in equids for several centuries, but this 
disease was eradicated from most countries by the mid-1900s. Outbreaks are now 
uncommon and reported from limited geographic areas. In non-endemic regions, 
cases may be seen in people who work with the causative organism, Burkholderia 
mallei, in secure laboratories. An infection was reported in a U.S. researcher in 2000. 
Glanders is also considered to be a serious bioterrorist threat: B. mallei has been 
weaponized and tested against humans, and it was also used as a biological weapon 
against military horses in past wars. 
Etiology 
Glanders results from infection by Burkholderia mallei, a Gram negative rod in 
the family Burkholderiaceae. This organism was formerly known as Pseudomonas 
mallei. It is closely related to and appears to have evolved from the agent of 
melioidosis, Burkholderia pseudomallei.  
Species Affected 
The major hosts for B. mallei are horses, mules and donkeys. Most other 
domesticated mammals can be infected experimentally (pigs and cattle were reported 
to be resistant), and naturally occurring clinical cases have been reported in some 
species. Members of the cat family seem to be particularly susceptible, with cases 
documented in domesticated cats, tigers, lions, leopards and other felids. Deaths have 
also been reported in other carnivores that ate glanderous meat, including dogs, bears, 
wolves, jackals and hyenas, and clinical cases were described in dromedary camels. 
Hamsters and guinea pigs are susceptible to glanders after experimental inoculation, 
but mice do not become ill unless the dose of organisms is high, and laboratory rats 
are resistant to infection. Wild rodents (e.g., field mice and voles) can also be infected 
experimentally. Birds are highly resistant.  
Zoonotic potential 
B. mallei affects humans. 
Geographic Distribution 
Glanders is thought to be endemic in parts of the Middle East, Asia, Africa and 
Central and South America. This disease has sometimes reemerged in countries where 
it appeared to be absent or was limited to small foci of infection (e.g., India in 2006). 
It has been eradicated from western Europe, Canada, the U.S., Australia, Japan and 
some other countries, and it was never endemic in New Zealand. The geographic 
distribution of B. mallei can be difficult to determine precisely, as cross-reactions 
with B. pseudomallei interfere with serological surveys.  
Transmission 
Glanders is mainly transmitted by contact with infected horses, mules and 
donkeys, most often via their respiratory secretions and exudates from skin lesions. 
Chronically or subclinically infected equids can shed B. mallei intermittently or 
constantly. This organism can enter the body by contamination of skin abrasions and 
mucous membranes, or inhalation in aerosols. Equids often become infected when 
they ingest B. mallei in contaminated food or water, and carnivores when they eat 
contaminated meat. There are reports of venereal transmission from stallions to 
mares, and vertical transmission from the dam.  
B. mallei is readily spread on fomites including harnesses, grooming tools, and 
food and water troughs. Flies might act as mechanical vectors. Although this 
organism is inactivated by heat and sunlight, its survival is prolonged in wet or humid  
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environments. It was reported to survive for up to 6 weeks 
in some infected stables, and one early report suggested that 
it might remain viable in room temperature water for up to 
100 days. Under most conditions, however, it is not thought 
likely to survive in the environment for more than 2 weeks. 
Humans can be infected by contact with sick animals, 
contaminated fomites, tissues or bacterial cultures. The 
organism is thought to enter the body through wounds and 
abrasions in the skin, and by ingestion or inhalation. 
Transmission through unbroken skin has been reported, but 
not proven (minor breaks in the skin could also explain 
these cases). Most laboratory-acquired infections have 
occurred during routine handling and processing of cultures 
or samples, rather than after injuries or accidents. Rare 
cases of person-to-person transmission have been reported 
in family members who nursed sick individuals. Two cases 
were thought to have been sexually transmitted.  
Disinfection 
B. mallei is susceptible to many common disinfectants 
including 1% sodium hypochlorite, 70% ethanol, 2% 
glutaraldehyde, iodine, benzalkonium chloride, mercuric 
chloride in alcohol and potassium permanganate. It is less 
susceptible to phenolic disinfectants. This organism can be 
destroyed by heating to 55°C (131°F) for 10 minutes, or 
exposure to ultraviolet irradiation. In the environment, B. 
mallei is susceptible to drying and sunlight. 
Infections in Animals 
Incubation Period 
The incubation period in equids is reported to range 
from a few days to many months, but many cases become 
apparent in 2-6 weeks. Infections can be latent for varying 
periods. Experimental infections can result in fever after a 
day or two, and other clinical signs after 3 days. Less is 
known about the incubation period in other species; 
however, some cats developed clinical signs 8-14 days after 
eating infected meat. 
Clinical Signs 
Horses, donkeys and mules 
In equids, glanders is traditionally categorized into 
nasal, pulmonary and cutaneous forms, based on the most 
commonly affected sites.  
In the nasal form, deep ulcers and nodules develop 
inside the nasal passages, resulting in a thick, 
mucopurulent, sticky, yellowish discharge. This discharge 
can be copious, may be unilateral or bilateral, and can 
become bloody. The ulcers may coalesce over wide areas, 
and nasal perforation is possible. Healed ulcers become 
star–shaped scars, which may be found concurrently with 
nodules and ulcers. The regional (submaxillary) lymph 
nodes become enlarged bilaterally or unilaterally. They are 
usually indurated in acute illness, and may occasionally 
suppurate and drain. Nasal infections can spread to involve 
the lower respiratory tract. 
Pulmonary involvement occurs in most clinical cases, 
often in combination with other forms of glanders. Affected 
animals develop nodules and abscesses in the lungs, or 
bronchopneumonia in some cases. Some infections are 
inapparent; others are characterized by mild to severe 
respiratory signs (e.g., coughing, dyspnea), with fever or 
febrile episodes and progressive debilitation. If the upper 
respiratory tract was not involved initially, it may become 
infected via discharges from pulmonary abscesses. 
In the cutaneous form (known as ‘farcy’) multiple 
nodules develop in the skin, along the course of lymphatic 
vessels. These nodules often rupture and ulcerate, 
discharging an oily, thick yellow exudate. Glanders ulcers 
heal very slowly, often continuing to discharge fluid, 
although dry ulcers may also be seen. The regional 
lymphatics and lymph nodes become chronically enlarged, 
and the lymphatics are filled with a purulent exudate. Some 
animals also have swelling of the joints, painful edema of 
the legs or glanderous orchitis (in intact males). While skin 
lesions may appear anywhere, they are reported to be most 
common on the inner thighs, limbs and abdomen. Animals 
with cutaneous glanders can remain in good condition for a 
time, but they eventually become debilitated and die. 
Clinical cases are often a combination of forms, and 
may be acute (or subacute), chronic or latent, depending on 
the animal’s resistance to disease. Donkeys and mules often 
develop acute glanders after exposure, although mules 
appear to be somewhat more resistant and the course of the 
illness may be slower. Acute glanders is characterized mainly 
by nasal and respiratory involvement, with clinical signs that 
commonly include a high fever, decreased appetite/ weight 
loss, depression, swelling of the nostrils, bouts of coughing 
and progressive dyspnea. An initial watery nasal discharge 
(often unilateral at first) can develop into the classic signs of 
the nasal form. There may also be a purulent ocular 
discharge. Neurological signs were reported in 
experimentally infected horses, possibly as the result of 
secondary bacterial (Streptococcus zooepidemicus) infection 
of the brain due to a compromised blood-brain barrier. 
Animals with the acute form of glanders usually die in a few 
days to a few weeks from septicemia and respiratory failure. 
Horses usually develop chronic glanders. This form 
can also be seen in some mules. Chronic glanders develops 
insidiously and lasts for months to years, with periodic 
episodes of exacerbation, resulting in slowly progressive 
debilitation. Although the initial signs may be mild and 
easily overlooked (e.g., intermittent low fever and slightly 
labored breathing), progression of the lesions results in 
listlessness, generalized weakness and wasting, with an 
intermittent cough. Some animals become lame, with 
swelling of the joints in the hindquarters, or have 
hematuria, polyuria, diarrhea, epistaxis or orchitis. Signs of 
nasal glanders or skin involvement may be seen, and 
stressors can result in acute bronchopneumonia. Extension 
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of lesions to the brain has been reported in at least one case. 
Chronic glanders is eventually fatal in most animals, 
although a few may recover clinically while remaining 
carriers. Animals that recover from glanders can relapse. 
In latent cases, lesions may occur sporadically in the 
lungs and other internal organs. The clinical signs are 
usually minimal, and most often consist only of intermittent 
low fever, nasal discharge and/or occasional labored 
breathing. Latent glanders is most common in resistant 
species, such as horses. 
Other species 
The clinical signs in naturally infected dromedary 
camels were similar to those in equids, and included fever, 
lethargy, emaciation, and nodules and ulcers in the nasal 
passages, with severe mucopurulent discharge. In cats that 
ate infected meat, nodules and ulcers were found in the 
nasal passages and on the conjunctivae, as well as deeper in 
the respiratory tract. Affected cats also had a purulent 
yellowish nasal discharge that sometimes became bloody. 
Additional clinical signs included swelling of the lymph 
nodes and dyspnea, and affected cats usually died in 1 to 2 
weeks. Similar respiratory, nasal and nonspecific signs 
(e.g., anorexia, depression) have been reported in large 
felids during outbreaks at zoos. Some of these animals also 
vomited, had skin ulcers or developed swelling of the face 
and head.  
Post-Mortem Lesions      Click to view images 
Nodules, granulomas and/or ulcers may be detected in 
various tissues of equids with glanders. Glanders nodules 
are firm, round and usually about 1 cm. in diameter, with a 
caseous or calcified center. They are typically surrounded 
by areas of inflammation. The upper respiratory tract is 
often affected, with ulcers, nodules and/or stellate scars in 
the nasal passages, larynx and other tissues. Internally, 
nodules are most likely to be found in the lungs, 
particularly beneath the pleura. The lungs may also contain 
diffuse miliary granulomatous nodules, and in acute or 
exacerbated cases, there may be evidence of severe 
bronchopneumonia. In addition, nodules and other lesions 
may be detected in other visceral organs, particularly the 
liver and spleen. Some animals have had bone lesions, and 
abscesses were found in the muscles of infected racehorses. 
Swollen lymphatics, with chains of nodules and ulcerated 
nodules, may be noted in the skin, while the lymph nodes 
may be enlarged, congested and/or fibrotic, and can contain 
abscesses. Orchitis may be seen in males.  
Similar lesions have been reported in other species. 
Diagnostic Tests 
Glanders can be diagnosed by culturing B. mallei from 
lesions, lymph nodes, and nasal or other respiratory 
exudates. This organism is uncommonly detected in blood. 
Bacteriological diagnosis can be difficult when the animal 
is in the early stages of disease or subclinically infected. 
Detailed guidelines for isolating B. mallei, which grows 
best on media enriched with glycerol, have been published 
by the World Organization for Animal Health (OIE) and 
other sources. While this organism can also grow on 
ordinary culture media (though not well on MacConkey 
agar), its slow growth and the potential for overgrowth by 
other bacteria may make isolation difficult. If necessary, it 
can also be recovered by inoculation into guinea pigs. Once 
isolated, B. mallei is usually identified with biochemical 
tests. The absence of motility is important in distinguishing 
it from other members of the Pseudomonas group, 
including B. pseudomallei. It can be misidentified by 
automated bacterial identification systems. Due to the risks 
of human infection, isolates suspected to be B. mallei are 
typically sent to a reference laboratory for identification. 
Genetic techniques available in specialized laboratories 
(e.g., PCR–restriction fragment length polymorphism, 
pulse-field gel electrophoresis, 16S rRNA sequencing) can 
distinguish B. mallei from its close relative B. 
pseudomallei. Several PCR tests have been described, but 
many have not yet been thoroughly evaluated with clinical 
samples. A few are reported to differentiate B. mallei from 
B. pseudomallei. Antigen detection assays (e.g., latex 
agglutination, immunofluorescence) have been investigated. 
B. mallei can sometimes be observed in smears from 
fresh lesions, where it is usually present in large numbers, 
although the staining may be weak or irregular. It can be 
difficult to find in older lesions or tissue sections. This 
organism can be stained with methylene blue, Wright or 
Gram stains, but some authors report that it stains best with 
Giemsa. It is a Gram negative, straight or slightly curved 
rod; organisms from clinical samples and young cultures 
appear as rods, while bacteria from older cultures can be 
pleomorphic. In tissue sections, it may have a beaded 
appearance.  
A hypersensitivity reaction called the mallein test was 
used in glanders eradication programs, and is still used to 
detect infected equids in some countries. In the 3 versions 
of the mallein test, a protein fraction of B. mallei is either 
injected into the eyelid (intradermo-palpebral test), 
administered in eyedrops, or injected subcutaneously at a 
site other than the eye. The intradermo-palpebral test is 
considered to be the most reliable and sensitive version. 
Reactors in this test develop marked eyelid swelling after 1 
to 2 days. There may also be a purulent ocular discharge 
and an elevated body temperature. Conjunctivitis occurs 
after administration in eyedrops, and a firm, painful 
swelling with raised edges is seen within 24 hours after 
subcutaneous (non-ocular) injection. Mallein testing can 
cause transient false positives in subsequent serological 
tests, and such reactivity could become permanent if the 
animal is tested repeatedly. It can give inconclusive results 
in acute glanders, or in the late stages of chronic disease. 
Cross-reactivity has also been reported. 
A variety of serologic tests have also been used to 
diagnose glanders and/or detect infected horses in 
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surveillance and import testing. Complement fixation and 
ELISAs are currently considered to be the most accurate 
and reliable assays in equids, although other tests may also 
meet this standard once they have been fully evaluated. 
Complement fixation has also been used to diagnose 
glanders in other animals, including camels and large zoo 
cats, and an ELISA test was positive in an infected camel. 
Immunoblotting appears promising in equids, and might be 
used in combination with other assays. A rose bengal plate 
agglutination test is sometimes employed in Russia. Cross-
reactivity can be an issue in serological tests, and false 
negatives also occur, especially in chronically infected, 
debilitated, pregnant or old animals. Complement fixation 
is reported to detect chronically infected animals during 
episodes of exacerbation. Most serological tests cannot 
distinguish whether the animal has antibodies to B. mallei 
or B. pseudomallei.  
Treatment 
Some antibiotics may be effective against glanders, but 
treatment is often not allowed outside endemic areas. 
Treatment can be risky even in these regions, as infections 
can spread to humans and other animals, and treated 
animals may become asymptomatic carriers.  
Designing effective treatments for glanders is 
complicated by differences in antibiotic susceptibility 
patterns between B. mallei isolates, and the inability of 
some drugs to penetrate into the host cells where this 
organism replicates. Treatment protocols that might be able 
to eliminate B. mallei have been published recently, but 
they have not yet been fully evaluated. Some require 
treatment for several months, using multiple drugs. 
Control  
Disease reporting 
A quick response is vital for containing outbreaks in 
glanders-free regions. Veterinarians who encounter or 
suspect this disease should follow their national and/or local 
guidelines for disease reporting. In the U.S., state or federal 
veterinary authorities should be informed immediately. 
Prevention 
During outbreaks in non-endemic regions, animals that 
test positive are usually euthanized, and the premises are 
quarantined, cleaned and disinfected. Carcasses, 
contaminated bedding and food should be safely destroyed 
(e.g., burned or buried), and equipment and other fomites 
should be disinfected. Import testing (e.g., by serology) is 
used to help exclude infected animals from regions where 
glanders has been eliminated.  
In endemic areas, susceptible animals should be kept 
away from communal feeding and watering areas, since 
glanders is more common where animals congregate. 
Routine testing and euthanasia of infected animals can 
eradicate the disease or reduce its incidence. Meat from 
infected equids should not be fed to other animals (or used 
for human consumption). Vaccines are not available. 
Morbidity and Mortality 
Glanders can spread widely when large numbers of 
animals are in close contact. This disease is also reported to 
be more common in animals that are undernourished or 
otherwise in poor condition. A high percentage of 
infections may be subclinical or latent. Although acute 
glanders is usually fatal within a short period, animals with 
the chronic form can sometimes survive for years. Mortality 
rates are thought to be high, but estimates are difficult to 
make because infected animals are usually euthanized to 
prevent them from spreading the disease. 
Cases of glanders are reported infrequently in animals 
other than equids. Among carnivores, felids appear to be 
particularly susceptible: more than one outbreak has been 
reported in captive large felids, and cases have been seen in 
domesticated cats.  
Infections in Humans 
Incubation Period 
The incubation period for acute glanders is reported to 
be 1 to 14 days, with most cases of localized disease 
becoming apparent within 5 days. Chronic cases can take 
months to appear. 
Clinical Signs 
Forms of glanders that have been described in humans 
include septicemia, pulmonary infection, acute localized 
infection and chronic disease. One form can progress to 
another, and combinations of syndromes occur. Some 
patients have had a biphasic illness, separated by remissions 
lasting a few days to several weeks. 
Localized infections are characterized by nodules, 
abscesses and/or ulcers in the mucous membranes skin 
and/or subcutaneous tissues at the site of inoculation. In 
skin, the initial lesion may appear as a blister that gradually 
develops into an ulcer. Involvement of the lymphatics in the 
area results in lymphangitis with numerous foci of 
suppuration. When the mucous membranes are involved, a 
mucopurulent, sometimes blood–tinged, discharge may be 
seen. The nose and the face may swell if the nasal passages 
are affected, and local tissue destruction can occur. 
Localized lesions may be accompanied by systemic signs of 
illness, including fever (which may be low grade and 
fluctuating), sweats, malaise, headache and swelling of the 
regional lymph nodes, sometimes with abscesses. 
Mucosal or skin infections may disseminate to other 
organs. The lungs, spleen and liver are often affected, but 
any tissue including the muscles can be involved. The 
clinical signs can be nonspecific in disseminated cases (e.g., 
nausea, dizziness, night sweats, myalgia, severe headache, 
weight loss). A papular or pustular rash may also be seen. 
Disseminated infections often progress to septicemia.  
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The pulmonary form can occur acutely after inhaling B. 
mallei, but organisms may also reach the lungs by localized 
or hematogenous spread from other forms. Pulmonary 
abscesses, pleural effusion and pneumonia are 
characteristic. The symptoms include fever and other 
nonspecific signs (e.g., chills, sweats, headache, myalgia), 
coughing and chest pain, progressing to dyspnea. 
Lymphangitis, nasal involvement and gastrointestinal signs 
may also be seen, and skin abscesses can develop up to 
several months after organisms are inhaled. Untreated 
pulmonary disease often develops into septicemia.  
In the septicemic form, fever, chills, myalgia, headache 
and pleuritic chest pain may develop acutely. Other 
symptoms may include flushing, a pustular or papular rash, 
lymphadenopathy, cellulitis, cyanosis, jaundice, 
photophobia, diarrhea and granulomatous or necrotizing 
lesions, tachycardia and mild hepatomegaly or 
splenomegaly. Multi-organ failure is common, and death 
can occur rapidly.  
Chronic glanders is characterized by multiple 
abscesses, nodules and ulcers in various tissues, with 
periodic recrudescence and milder symptoms than in acute 
cases. Weight loss, lymphadenopathy and lymphangitis are 
common. This form of the disease has been reported to last 
up to 25 years. 
Diagnostic Tests 
Glanders can be diagnosed by culturing B. mallei from 
lesions, as in animals. This organism may also be found in 
sputum, blood or urine, although blood cultures are often 
negative. PCR assays or antigen detection tests could be 
useful, though they are not employed routinely. Serology 
can be employed in diagnosis, if tests are available; 
however, there can be unexplained high background titers 
in some normal sera, and seroconversion tends to occur 
late. Many serological tests cannot distinguish reactions to 
other species of Burkholderia, including B. pseudomallei. 
The mallein test is not used in humans.  
Radiography is helpful in the pulmonary form, 
although it is not specific for glanders. The lesions can 
include bilateral bronchopneumonia, miliary nodules, 
segmental or lobar infiltrates, and cavitating lesions. 
Similar lesions may also be detected in other organs and 
tissues. 
Treatment 
Glanders is treated with antibiotics. The optimal 
treatment is still uncertain, but some treatment 
recommendations are available, and some cases have been 
treated successfully. Long-term treatment and/or multiple 
drugs may be necessary in some cases. Abscesses may need 
to be drained.  
Prevention 
Strict precautions, including appropriate personal 
protective equipment (PPE), should be taken when handling 
infected animals and contaminated fomites. Biosafety level 
3 practices are required for manipulating infected tissues 
and cultures. Postexposure prophylaxis with antibiotics 
might be used in some situations. No vaccine is available.  
Although person-to-person transmission is rare, human 
glanders patients should be isolated. Infection control 
precautions should be taken, and PPE, including disposable 
surgical masks, face shields, and gowns, should be used as 
appropriate during nursing.  
Morbidity and Mortality 
Glanders is a sporadic, and currently rare, disease that 
usually occurs in people who work with clinical samples or 
have frequent, close contact with infected horses and their 
tissues. Human epidemics have not been seen. 
Transmission from horses to humans may be inefficient; 
even when morbidity rates in horses are 5-30%, zoonotic 
disease is reported to be uncommon. However, some 
infections might be subclinical or mild; autopsy studies 
conducted in endemic areas found glanders-associated 
nodules in many people who had contact with horses. In 
laboratories, B. mallei is highly infectious, particularly 
when it is aerosolized. With aerosolized bacteria, morbidity 
rates up to 46% have been reported.  
Mortality rates are reported to be high in untreated 
glanders, with a case fatality rate of 95% or greater in 
septicemia and 90-95% in the pulmonary form. With 
treatment, the case fatality rates for these forms are reported 
to be as high as 40-50%. The estimated mortality for 
localized disease is 20% when treated; untreated cases often 
progress to other forms. Chronic glanders is reported to be 
difficult to treat, with a case fatality rate as high as 50% in 
spite of treatment. It should be noted that these estimates 
were based on historical cases (and possibly extrapolated 
from melioidosis in some cases), and mortality could be 
lower with modern supportive care and effective antibiotics. 
Internet Resources 
Centers for Disease Control and Prevention (CDC  
http://www.cdc.gov/glanders/    
eMedicine. Glanders and Melioidosis  
http://emedicine.medscape.com/article/830235-
overview  
FAO. Manual on Meat Inspection for Developing Countries 
http://www.fao.org/docrep/003/t0756e/t0756e00.htm  
Public Health Agency of Canada. Pathogen Safety  
Data Sheets  
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php 
The Merck Manual (Professional) 
http://www.merckmanuals.com/professional/index.html 
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The Merck Veterinary Manual. 
http://www.merckmanuals.com/vet/index.html 
United States Animal Health Association. Foreign Animal 
Diseases  
http://www.aphis.usda.gov/emergency_response/downl
oads/nahems/fad.pdf 
World Organization for Animal Health (OIE)  
http://www.oie.int/  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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